Bio-Techne
TECH
585 hedge funds and large institutions have $10.1B invested in Bio-Techne in 2025 Q4 according to their latest regulatory filings, with 88 funds opening new positions, 207 increasing their positions, 211 reducing their positions, and 70 closing their positions.
125% more funds holding in top 10
Funds holding in top 10: 4 → 9 (+5)
26% more first-time investments, than exits
New positions opened: 88 | Existing positions closed: 70
14% more capital invested
Capital invested by funds: $8.84B → $10.1B (+$1.27B)
8.26% more ownership
Funds ownership: 102.07% → 110.33% (+8.3%)
1% more funds holding
Funds holding: 577 → 585 (+8)
2% less repeat investments, than reductions
Existing positions increased: 207 | Existing positions reduced: 211
51% less call options, than puts
Call options by funds: $50.4M | Put options by funds: $103M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$152M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
+$88M |
| 3 |
SCM
SG Capital Management
Chicago,
Illinois
|
+$69.8M |
| 4 |
Morgan Stanley
New York
|
+$67.3M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$60.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$111M |
| 2 |
BAMCO Inc
New York
|
-$78.3M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$63.2M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$44.8M |
| 5 |
FGP
Freestone Grove Partners
San Francisco,
California
|
-$39.6M |
TECH Hedge Fund Activity: Q4 2025 in Review
585 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q4 2025, worth a combined $10.1B — up 14% from $8.84B a quarter earlier.
Buyers outnumbered sellers: 88 funds opened new TECH positions and 70 closed out — a net gain of 18 holders — while 207 added to existing stakes and 211 trimmed.
The largest buyer was Massachusetts Financial Services, adding an estimated $152M. The largest seller was Macquarie Group, cutting an estimated $111M.
- 585 institutional investors held Bio-Techne (TECH) as of Q4 2025, up from 577 in Q3 2025.
- Funds reported $10.1B of Bio-Techne stock for Q4 2025, up 14% quarter-over-quarter.
- 88 funds opened new Bio-Techne positions in Q4 2025 and 70 closed out, a net change of +18 holders.
- The largest Bio-Techne buyer in Q4 2025 was Massachusetts Financial Services, an estimated $152M added.
- The largest Bio-Techne seller in Q4 2025 was Macquarie Group, an estimated $111M sold.
Based on aggregated 13F filings for Q4 2025.